These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3629547)

  • 1. Release of plasminogen activator by pentoxifylline and its major metabolite.
    Klöcking HP; Hoffmann A; Markwardt F
    Thromb Res; 1987 Jun; 46(5):747-50. PubMed ID: 3629547
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the release of plasminogen activator.
    Markwardt F; Klöcking HP
    Thromb Res; 1976 Feb; 8(2):217-23. PubMed ID: 2993
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5'-hydroxyhexyl)xanthine, by high-performance liquid chromatography.
    Luke DR; Rocci ML
    J Chromatogr; 1986 Jan; 374(1):191-5. PubMed ID: 3949928
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of tissue-type plasminogen activator by platelet-activating factor.
    Klöcking HP; Markwardt F; Hoffmann A
    Thromb Res; 1985 May; 38(4):413-6. PubMed ID: 4040278
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
    Cummings DM; Ballas SK
    Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
    Kwong EC; Chen FC; Young LM
    Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.
    Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H
    J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pentoxifylline clearance by cimetidine.
    Luke DR; Rocci ML; Hoholick C
    J Pharm Sci; 1986 Feb; 75(2):155-7. PubMed ID: 3958924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced platelet aggregation by pentoxifylline stimulated prostacyclin release.
    Weithmann KU
    Vasa; 1981; 10(3):249-52. PubMed ID: 7025499
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of alpha-NAPAP on thrombin-induced release of plasminogen activator.
    Klöcking HP; Hoffmann A; Markwardt F
    Thromb Res; 1988 Oct; 52(1):71-3. PubMed ID: 3201399
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin-induced release of plasminogen activator.
    Markwardt F; Klöcking HP
    Haemostasis; 1977; 6(6):370-4. PubMed ID: 611049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography.
    Bryce TA; Burrows JL; Jolley KW
    J Chromatogr; 1985 Nov; 344():397-402. PubMed ID: 4086565
    [No Abstract]   [Full Text] [Related]  

  • 13. Pentoxifylline increases survival of mice in endotoxic shock.
    Schade UF; von der Bosch J; Schönharting M
    Prog Clin Biol Res; 1989; 301():223-7. PubMed ID: 2508103
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of pentoxifylline on the survival of skin flaps.
    Velanovich V
    Arch Otolaryngol Head Neck Surg; 1988 Jun; 114(6):681. PubMed ID: 3365343
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pentoxifylline ('Trental') on cochlear blood flow as measured by hydrogen wash-out.
    Maass B; Ludwig D
    Curr Med Res Opin; 1984; 9(1):52-5. PubMed ID: 6426863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pentoxifylline (Trental) and two analogues, BL 194 and HWA 448, on the release of plasminogen activators and von Willebrand factor in rats.
    Tranquille N; Emeis JJ
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):35-42. PubMed ID: 1719289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of platelet aggregation in vivo. III. Effect of pentoxifylline.
    Gastpar H; Ambrus JL; Ambrus CM; Spavento P; Weber FJ; Thurber LE
    J Med; 1977; 8(3-4):191-7. PubMed ID: 407320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system.
    Tappy L; Hauert J; Bachmann F
    Thromb Res; 1984 Jan; 33(2):117-24. PubMed ID: 6538346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of plasminogen activator by acetylcholine from the isolated perfused pig ear.
    Klöcking HP
    Thromb Res; 1979; 16(1-2):261-4. PubMed ID: 505422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.